Original Research
Published on 03 Mar 2022
Gene Promoter-Methylation Signature as Biomarker to Predict Cisplatin-Radiotherapy Sensitivity in Locally Advanced Cervical Cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.773438
- 4,552 views
- 6 citations
